The Challenge
Scaling AI across R&D and business units – speeding up drug discovery, clinical trials, and knowledge work.
The AI Solution
Enterprise-wide generative AI strategy, including deploying ChatGPT Enterprise for researchers and staff, AI assistants for analyzing 3D imaging and drafting clinical trial protocols.
Type of AI Used: Generative AI (LLMs for enterprise)
Results & Impact
By mid-2025, AstraZeneca trained ~12,000 employees on generative AI, with 85-93% of staff reporting productivity gains. 80% of medical writers found AI-generated protocol drafts useful.
